Medicine and Dentistry
Adipose Tissue
24%
Biological Marker
13%
Biopsy Technique
15%
Body Mass Index
13%
Cancer
24%
Cancer Cell
14%
Cancer Metabolism
10%
Cell Metabolism
6%
Clear Cell Renal Cell Carcinoma
12%
Computer Assisted Tomography
21%
Diseases
23%
Gamma-Aminobutyric Acid
14%
Ganglioglioma
14%
Gene Linkage
7%
Glioblastoma
10%
Glucose Metabolism
6%
Glycan
10%
In Vitro
6%
Lipogenesis
9%
Localized Disease
7%
Magnetic Resonance Imaging
52%
Magnetic Resonance Imaging of Prostate
7%
Malignant Neoplasm
39%
Matrix-Assisted Laser Desorption-Ionization
7%
Metabolism
17%
Metabolite
7%
Metabolomics
14%
Metastatic Carcinoma
20%
Multiparametric Magnetic Resonance Imaging
16%
Neoplasm
28%
Neuroendocrine Differentiation
6%
Obesity
6%
Oral Cancer
9%
Overall Survival
15%
Polyethylene Terephthalate
15%
Positron Emission Tomography
19%
Prostate Cancer
100%
Prostate Specific Antigen
7%
Prostatectomy
7%
Proteomics
9%
Radioactive Tracer
7%
Recurrent Disease
12%
Risk Stratification
7%
Sex Difference
21%
Solid Malignant Neoplasm
6%
Subcutaneous Fat
6%
Transgenic Mouse
12%
Tumor Metabolism
6%
Uterine Cancer
9%
Visceral Fat
21%
Keyphrases
Acetylcholine Receptor (AChR)
9%
Bitter Melon Extract
9%
Body Composition
13%
Body Composition Analysis
9%
Body Mass Index
8%
Calcium Carbonate Nanoparticles
9%
Cancer Genome Atlas
13%
Cancer Metabolism
10%
Clinically Significant Prostate Cancer
17%
Cocaine
9%
Computed Tomography
13%
Confidence Interval
8%
Extracellular pH
10%
Glioma
11%
Glycolysis
17%
Image Interpretation
8%
In Cancer
11%
Lipogenesis
9%
Magnetic Resonance Imaging
16%
Metabolic Pathway
23%
Metabolism
19%
Metastatic Disease
9%
Multiparametric MRI (mpMRI)
45%
N-glycan
8%
NCCN Guidelines
19%
Neuroendocrine Cancer
23%
Neuroendocrine Cells
11%
Neuroendocrine Phenotype
9%
Nicotinic Acetylcholine Receptor (nAChR)
9%
Obesity
13%
Oral Cancer
9%
Overall Survival
13%
Patients with Prostate Cancer
8%
PH-sensitive
10%
Poor Prognosis
15%
Positron Emission Tomography
15%
Prostate
22%
Prostate Cancer
72%
Recurrent Disease
9%
Renal Cell Carcinoma
14%
Sex Differences
27%
Sex-specific
9%
Solid Tumors
8%
Spatial Proteomics
9%
Subcutaneous Adipose Tissue
9%
Theranostic Platform
9%
Tumor
26%
Tumor Metabolism
8%
Visceral Adipose Tissue
9%
Visceral Fat
20%